
CHÉOS Scientist Dr. Joseph Puyat helped design the evaluation of the toolkit, in collaboration with colleagues at St Paul’s and VCH
Page template : index.php Search terms : Sort : Page :
CHÉOS Scientist Dr. Joseph Puyat helped design the evaluation of the toolkit, in collaboration with colleagues at St Paul’s and VCH
A new investigation from the CHÉOS Health Economics Program indicates the framework could speed up generic entry to Canadian public health plans
New study led by CHÉOS Scientist Dr. Anne Gadermann will explore the impact COVID-related school disruptions have had on student and teacher wellbeing.
A new analysis indicates many Canadians are not making use of virtual resources that could help them cope with the mental health impacts of COVID-19
Dr. Turgeon is an assistant professor at UBC and clinical pharmacist specialist at St. Paul’s Hospital. His research is centered on implementation science and cardiovascular pharmacotherapy
CHÉOS Scientist Dr. Christopher Fordyce chaired the writing of a new American Heart Association Scientific Statement, “Prevention of Complications in the Cardiac Intensive Care Unit”
Dr. Vigo is a psychiatrist, clinical psychologist, and public health specialist interested in understanding and improving mental health and substance use services
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV